STUDIES ON THE COMPARATIVE DISTRIBUTION AND BILIARY-EXCRETION OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN MICE AND RATS

被引：0
|
作者：
BROGGINI, M
COLOMBO, T
MARTINI, A
DONELLI, MG
机构：
[1] MARIO NEGRI INST PHARMACOL RES,ERITREA 62,I-20157 MILAN,ITALY
[2] FARMITALIA CARLO ERBA SPA,RIC & SVILUPPO,MILAN,ITALY
来源：
CANCER TREATMENT REPORTS | 1980年 / 64卷 / 8-9期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：897 / 904
页数：8
相关论文
共 50 条
  • [1] DISTRIBUTION OF 4'EPI-DOXORUBICIN IN HUMAN-TISSUES
    ITALIA, C
    PAGLIA, L
    TRABATTONI, A
    LUCHINI, S
    VILLAS, F
    BERETTA, L
    MARELLI, G
    NATALE, N
    BRITISH JOURNAL OF CANCER, 1983, 47 (04) : 545 - 547
  • [2] PHARMACOLOGIC DISTRIBUTION AND BILIARY-EXCRETION OF DOXORUBICIN ENTRAPPED IN CARDIOLIPIN LIPOSOMES IN RATS
    GOLDIN, A
    HARRIS, M
    SCHEIN, PS
    RAHMAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 363 - 363
  • [3] COMPARATIVE METABOLISM OF DOXORUBICIN (DX), 4'-EPI-DOXORUBICIN (E) AND 4'-DEOXY-DOXORUBICIN (D) - INVITRO AND INVIVO STUDIES
    WEENEN, H
    LANKELMA, J
    VANMAANEN, JMS
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 169 - 169
  • [4] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN
    BONFANTE, V
    VILLANI, F
    BONADONNA, G
    TUMORI JOURNAL, 1982, 68 (02): : 105 - 111
  • [5] Inhibition of NO synthase induction by an anticancer drug 4'-epi-doxorubicin in rats
    Sakai, T
    Muramatsu, I
    Hayashi, N
    Ishii, Y
    GENERAL PHARMACOLOGY, 1996, 27 (08): : 1367 - 1372
  • [6] ACTIVITY OF 4'-EPI-DOXORUBICIN ON NORMAL HEMATOPOIETIC PRECURSOR CELLS IN MICE
    SOBRERO, A
    MUZZULINI, C
    DAMORE, F
    BOGLIOLO, G
    MASSA, G
    GHIO, R
    PANNACCIULLI, I
    CANCER TREATMENT REPORTS, 1982, 66 (12): : 2061 - 2070
  • [7] CLINICAL TOXICITY OF 4'-EPI-DOXORUBICIN (EPIRUBICIN)
    GANZINA, F
    DIPIETRO, N
    MAGNI, O
    TUMORI, 1985, 71 (03) : 233 - 240
  • [8] PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH 4'-EPI-DOXORUBICIN IN NASOPHARYNGEAL CARCINOMA PATIENTS
    HU, OYP
    CHANG, SP
    JAME, JM
    CHEN, KY
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 24 (05) : 332 - 337
  • [9] PHARMACOKINETICS AND CENTRAL HEMODYNAMIC-EFFECTS OF DOXORUBICIN AND 4'-EPI-DOXORUBICIN IN THE PIG
    ANDERSSON, M
    DOMELLOF, L
    EKSBORG, S
    HAGGMARK, S
    JOHANSSON, G
    REIZ, S
    HERSLOF, A
    ACTA ONCOLOGICA, 1989, 28 (05) : 709 - 714
  • [10] LACK OF MUTAGENICITY BY DOXORUBICIN, 4'-EPI-DOXORUBICIN AND 4'-DEOXYDOXORUBICIN IN HUMAN-CELLS
    FERRERI, AM
    CAPUCCI, A
    GRILLI, MP
    ROCCHI, P
    PEROCCO, P
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1284 - 1284
12345